The role of the α2-adrenoceptor agonist dexmedetomidine in postsurgical sedation in the intensive care unit

Journal of Intensive Care Medicine

Volumn 18, Issue 1, 2003, Pages 29-41

  Martin, Eike ^a   Ramsay, Graham ^b   Mantz, Jean ^c   Sum Ping, S T John ^d  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c BICHAT HOSPITAL   (France)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

2 adrenoceptors; Anxiety; Cardiac artery bypass graft; Imidazoles; Respiratory system; Sympatholysis

Indexed keywords

DEXMEDETOMIDINE; MORPHINE; PROPOFOL; SODIUM CHLORIDE; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; HYPNOTIC SEDATIVE AGENT;

ARTICLE; BRADYCARDIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEDATION; ADOLESCENT; ADULT; AGED; ARTIFICIAL VENTILATION; BREATHING; CHEMICALLY INDUCED DISORDER; CONSCIOUS SEDATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MONITORING; DRUG POTENTIATION; FEMALE; HEART RATE; INTENSIVE CARE; INTRAVENOUS DRUG ADMINISTRATION; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; POSTOPERATIVE CARE;

ADOLESCENT; ADRENERGIC ALPHA-AGONISTS; ADULT; AGED; AGED, 80 AND OVER; BRADYCARDIA; CONSCIOUS SEDATION; DEXMEDETOMIDINE; DOUBLE-BLIND METHOD; DRUG MONITORING; FEMALE; HEART RATE; HUMANS; HYPNOTICS AND SEDATIVES; HYPOTENSION; INFUSIONS, INTRAVENOUS; INTENSIVE CARE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; POSTOPERATIVE CARE; PROPOFOL; RECEPTORS, ADRENERGIC, ALPHA-2; RESPIRATION; VENTILATOR WEANING;

EID: 0142094416     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066602239122     Document Type: Article

References (36)

1. Mangano DT. Peri-operative cardiovascular morbidity: new developments. Bailliere's Clin Anaesthesiol. 1999;13:335-338.
2. Ostermann ME, Keenan SP, Seiferling RA, Sibbald WJ. Sedation in the intensive care unit: a systematic review. JAMA. 2000;283:1451-1459.
3. Westcott C. The sedation of patients in intensive care units: a nursing review. Intensive Crit Care Nurse. 1995;11(1):26-31.
4. Hall RI, Sandham D, Cardinal P, et al. Propofol vs midazolam for ICU sedation: a Canadian multicenter randomized trial. Chest. 2001;119:1151-1159.
5. Shafer SL. Advances in propofol pharmacokinetics and pharmacodynamics. J Clin Anesth. 1993;5(6 suppl 1):14S-21S.
6. Young C, Knudsen N, Hilton A, Reves JG. Sedation in the intensive care unit. Crit Care Med. 2000;28:854-866.
7. Jacobi J, Fraser GL, Coursin DB, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med. 2002;30:119-141.
8. Practice guidelines for sedation and analgesia by non-anesthesiologists: a report by the American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists. Anesthesiology. 2002;96:1004-1017.
9. Khan ZP, Ferguson CN, Jones RM. Alpha-2 and imidazoline receptor agonists: their pharmacology and therapeutic role. Anaesthesia. 1999;54:146-165.
10. Flacke J, Bloor B, Flacke W, et al. Reduced narcotic requirement by clonidine with improved hemodynamic and adrenergic stability in patients undergoing coronary artery bypass surgery. Anesthesiology. 1987;67:11-19.
11. Gabriel JS, Gordin V. Alpha 2 agonists in regional anesthesia and analgesia [review]. Curr Opin Anaesthesiol. 2001;14:751-753.
12. Bailey PL, Sperry RJ, Johnson GK, et al. Respiratory effects of clonidine alone and combined with morphine, in humans. Anesthesiology. 1991;74(1):43-48.
13. Venn RM, Hell J, Grounds RM. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care. 2000;4:302-308.
14. De Noyer M, Laveleye F, Vauquelin G, Gobert J, Wulfert E. Mivazerol, a novel compound with high binding specificity for alpha a2 adrenergic receptors: binding studies on different human and rat membrane preparations. Neurochem Int. 1994;24:221-229.
15. Scheinin B, Lindgren L, Randell T, Scheinin H, Scheinin M. Dexmedetomidine attenuates sympathoadrenal responses to tracheal intubation and reduces the need for thiopentone and perioperative fentanyl. Br J Anaesth. 1992;68:126-131.
16. Aho M, Scheinin M, Lehtinen AM, Erkola O, Vuorinen J, Korttila K. Intramuscularly administered dexmedetomidine attenuates hemodynamic and stress hormone responses to gynecologic laparoscopy. Anesth Analg. 1992;75:932-939.
17. Talke P, Richardson CA, Scheinin M, Fisher DM. Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine. Anesth Analg. 1997;85:1136-1142.
18. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology. 2000;93:382-394.
19. Talke P, Chen R, Thomas B, et al. The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth Analg. 2000;90:834-839.
20. Venn RM, Bryant A, Hall GM, Grounds RM. Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post-operative patients needing sedation in the intensive care unit. Br J Anaesth. 2001;86:650-656.
21. Venn RM, Steele A, Grounds RM. Intensive care sedation: the alpha-2 agonists. In: Vincent JL, ed. Yearbook of Intensive Care and Emergency Medicine. Berlin: Springer-Verlag; 2000:414-425.
22. Bradley C. Dexmedetomidine-a novel sedative for postoperative sedation. Intensive Crit Care Nurse. 2000;16:328-329.
23. Ramsay MAE, Savege TM, Simpson BRJ, Goodwin R. Controlled sedation with alphaxalone-alphadolone. Br Med J. 1974;2:656-659.
24. Hall JE, Uhrich TD, Barney JA, Arain SR, Ebert TJ. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg. 2000;90:699-705.
25. Aho M, Lehtinen AM, Erkola O, Kallio A, Korttila K. The effect of intravenously administered dexmedetomidine on perioperative hemodynamics and isoflurane requirements in patients undergoing abdominal hysterectomy. Anesthesiology. 1991;74:997-1002.
26. Jalonen J, Hynynen M, Kuitunen A, et al. Dexmedetomidine as an anesthetic adjunct in coronary artery bypass grafting. Anesthesiology. 1997;86:331-345.
27. Venn RM, Bradshaw CJ, Spencer R, et al. Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia. 1999;54:1136-1142.
28. Bloor BC, Ward DS, Belleville JP, Maze M. Effects of intravenous dexmedetomidine in humans: II: hemodynamic changes. Anesthesiology. 1992;77:1134-1142.
29. Jalonen J, Halkola L, Kuttila K, et al. Effects of dexmedetomidine on coronary hemodynamics and myocardial oxygen balance. J Cardiothorac Vasc Anesth. 1995;9:519-524.
30. 2-adrenergic agonists and peri-operative ischaemia. Anaesth Pharmacol Rev. 1993;1:310-315.
31. MSPI-Europe Research Group. Perioperative sympatholysis: beneficial effect of the a2 adrenoceptor agonist mivazerol on hemodynamic stability and myocardial ischemia. Anesthesiology. 1997;86:346-363.
32. Oliver M, Goldman B, Julian D, Holme I. Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (FMIT). Anesthesiology. 1999;91:951-96l.
33. Mangano D, Layug E, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery: multicenter study of Perioperative Ischemia Research Group. N Engl J Med. 1996;335:1713-1720.
34. Erratum, N Engl J Med. 1997;336:1039.
35. Raby K, Brull S, Timimi F, et al. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg. 1999;88:477-482.
36. Lawrence CJ, Prinzen FW, De Lange S. The effect of dexmedetomidine on the balance of myocardial energy requirement and oxygen supply and demand. Anesth Analg. 1996;82:544-550.